200 related articles for article (PubMed ID: 32069017)
1. Computational Insight into the Binding Profile of the Second-Generation PET Tracer PI2620 with Tau Fibrils.
Kuang G; Murugan NA; Zhou Y; Nordberg A; Ågren H
ACS Chem Neurosci; 2020 Mar; 11(6):900-908. PubMed ID: 32069017
[TBL] [Abstract][Full Text] [Related]
2. Cryptic Sites in Tau Fibrils Explain the Preferential Binding of the AV-1451 PET Tracer toward Alzheimer's Tauopathy.
Murugan NA; Nordberg A; Ågren H
ACS Chem Neurosci; 2021 Jul; 12(13):2437-2447. PubMed ID: 34152739
[TBL] [Abstract][Full Text] [Related]
3. Dissecting the Binding Profile of PET Tracers to Corticobasal Degeneration Tau Fibrils.
Zhou Y; Li J; Nordberg A; Ågren H
ACS Chem Neurosci; 2021 Sep; 12(18):3487-3496. PubMed ID: 34464084
[TBL] [Abstract][Full Text] [Related]
4. Different Positron Emission Tomography Tau Tracers Bind to Multiple Binding Sites on the Tau Fibril: Insight from Computational Modeling.
Murugan NA; Nordberg A; Ågren H
ACS Chem Neurosci; 2018 Jul; 9(7):1757-1767. PubMed ID: 29630333
[TBL] [Abstract][Full Text] [Related]
5. Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau Protofibrils.
Li J; Kumar A; Långström B; Nordberg A; Ågren H
ACS Chem Neurosci; 2023 Sep; 14(18):3528-3539. PubMed ID: 37639522
[TBL] [Abstract][Full Text] [Related]
6. The Sensitivity of Tau Tracers for the Discrimination of Alzheimer's Disease Patients and Healthy Controls by PET.
Mohammadi Z; Alizadeh H; Marton J; Cumming P
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830659
[TBL] [Abstract][Full Text] [Related]
7. Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains.
Malarte ML; Gillberg PG; Kumar A; Bogdanovic N; Lemoine L; Nordberg A
Mol Psychiatry; 2023 Mar; 28(3):1272-1283. PubMed ID: 36447011
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic Insight into the Binding Profile of DCVJ and α-Synuclein Fibril Revealed by Multiscale Simulations.
Kuang G; Murugan NA; Ågren H
ACS Chem Neurosci; 2019 Jan; 10(1):610-617. PubMed ID: 30277753
[TBL] [Abstract][Full Text] [Related]
9. Discriminatory ability of next-generation tau PET tracers for Alzheimer's disease.
Yap SY; Frias B; Wren MC; Schöll M; Fox NC; Årstad E; Lashley T; Sander K
Brain; 2021 Sep; 144(8):2284-2290. PubMed ID: 33742656
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Bioevaluation of 2-Styrylquinoxaline Derivatives as Tau-PET Tracers.
Wu N; Zhang L; Zhang X; Zhang Q; Liu J; Li Y; Yan XX; Liang Y; Zhang J; Cui M
Mol Pharm; 2023 Nov; 20(11):5865-5876. PubMed ID: 37852240
[TBL] [Abstract][Full Text] [Related]
11. Candidate PET Radioligand Development for Neurofibrillary Tangles: Two Distinct Radioligand Binding Sites Identified in Postmortem Alzheimer's Disease Brain.
Cai L; Qu B; Hurtle BT; Dadiboyena S; Diaz-Arrastia R; Pike VW
ACS Chem Neurosci; 2016 Jul; 7(7):897-911. PubMed ID: 27171905
[TBL] [Abstract][Full Text] [Related]
12. Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer's disease cases.
Malarte ML; Nordberg A; Lemoine L
Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1093-1102. PubMed ID: 32970217
[TBL] [Abstract][Full Text] [Related]
13. Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging.
Murugan NA; Chiotis K; Rodriguez-Vieitez E; Lemoine L; Ågren H; Nordberg A
Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1369-1382. PubMed ID: 30919054
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles.
Hostetler ED; Walji AM; Zeng Z; Miller P; Bennacef I; Salinas C; Connolly B; Gantert L; Haley H; Holahan M; Purcell M; Riffel K; Lohith TG; Coleman P; Soriano A; Ogawa A; Xu S; Zhang X; Joshi E; Della Rocca J; Hesk D; Schenk DJ; Evelhoch JL
J Nucl Med; 2016 Oct; 57(10):1599-1606. PubMed ID: 27230925
[TBL] [Abstract][Full Text] [Related]
15. Molecular Simulations Reveal Distinct Energetic and Kinetic Binding Properties of [
Künze G; Kümpfel R; Rullmann M; Barthel H; Brendel M; Patt M; Sabri O
ACS Chem Neurosci; 2022 Jul; 13(14):2222-2234. PubMed ID: 35762647
[TBL] [Abstract][Full Text] [Related]
16. Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with
Lohith TG; Bennacef I; Vandenberghe R; Vandenbulcke M; Salinas CA; Declercq R; Reynders T; Telan-Choing NF; Riffel K; Celen S; Serdons K; Bormans G; Tsai K; Walji A; Hostetler ED; Evelhoch JL; Van Laere K; Forman M; Stoch A; Sur C; Struyk A
J Nucl Med; 2019 Jan; 60(1):107-114. PubMed ID: 29880509
[No Abstract] [Full Text] [Related]
17. Free Energy Profile for Penetration of Pittsburgh Compound-B into the Amyloid β Fibril.
Zou R; Kuang G; Ågren H; Nordberg A; Långström B; Tu Y
ACS Chem Neurosci; 2019 Mar; 10(3):1783-1790. PubMed ID: 30698013
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Evaluation of
Honer M; Gobbi L; Knust H; Kuwabara H; Muri D; Koerner M; Valentine H; Dannals RF; Wong DF; Borroni E
J Nucl Med; 2018 Apr; 59(4):675-681. PubMed ID: 28970331
[TBL] [Abstract][Full Text] [Related]
19. Pick's Tau Fibril Shows Multiple Distinct PET Probe Binding Sites: Insights from Computational Modelling.
Mishra SK; Yamaguchi Y; Higuchi M; Sahara N
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396273
[TBL] [Abstract][Full Text] [Related]
20. 18F-MK-6240 PET for early and late detection of neurofibrillary tangles.
Pascoal TA; Therriault J; Benedet AL; Savard M; Lussier FZ; Chamoun M; Tissot C; Qureshi MNI; Kang MS; Mathotaarachchi S; Stevenson J; Hopewell R; Massarweh G; Soucy JP; Gauthier S; Rosa-Neto P
Brain; 2020 Sep; 143(9):2818-2830. PubMed ID: 32671408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
